Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound (Q46437949)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2005
edit
Language Label Description Also known as
English
Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound
scientific article published in March 2005

    Statements

    Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit